Iomeron (Iomeprol)

Iomeron, an iodinated contrast media, is employed in diagnostic imaging procedures that require enhanced X‑ray attenuation.

• Angiography: provides high‑contrast vascular images to support diagnosis and interventional procedures.
• Arthrography: delineates joint spaces and structures for accurate orthopedic evaluation.
• Computed tomography (CT) imaging: improves soft‑tissue and organ visualization for comprehensive radiologic assessment.

• Iomeprol contains a high density of iodine atoms that absorb X‑ray photons, increasing attenuation of the X‑ray beam in the tissues where it distributes. After intravenous, intra‑arterial, or intra‑articular administration, the agent remains largely within the extracellular fluid and vascular compartments, creating a radiopaque contrast that highlights vessels, organs, and joint spaces on radiographic and CT images.

Iomeron may be associated with a range of adverse reactions, from mild to severe.

Common Side Effects

• Warmth or flushing sensation during injection.
• Metallic taste in the mouth.
• Nausea or mild vomiting.
• Headache.
• Transient urticaria or skin itching.
• Mild hypotension.

Serious or Rare Side Effects

• Anaphylactoid or severe allergic reaction, including bronchospasm.
• Acute kidney injury, especially in patients with pre‑existing renal impairment.
• Thyroid function disturbances due to iodine load.
• Seizures or neurologic events.
• Cardiac arrhythmias or myocardial ischemia.

Prior to administering Iomeron, clinicians should observe several precautionary measures to minimize risk.

• Assess renal function: evaluate serum creatinine and eGFR before use.
• Review iodine allergy history: avoid in patients with known hypersensitivity to iodinated contrast.
• Ensure adequate hydration: encourage fluid intake before and after the procedure.
• Use the lowest effective dose: tailor volume to the specific imaging study.
• Monitor thyroid status: consider thyroid function tests in patients at risk.
• Store at room temperature: keep in original container, protect from light and moisture.

Iomeron can interact with other substances, influencing safety or efficacy.

Major Interactions (Avoid)

• Concurrent administration of other iodinated contrast agents: increases total iodine load.
• High‑dose iodine supplements or thyroid medications: may exacerbate thyroid dysfunction.
• Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs) in patients with renal impairment: heightens risk of kidney injury.

Moderate Interactions (Monitor Closely)

• Metformin: temporary discontinuation may be required to prevent lactic acidosis in renal‑compromised patients.
• Diuretics: may affect fluid balance and renal clearance of the contrast.
• Beta‑blockers: may mask signs of contrast‑induced hypertension.